Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Illumina Rises On Unusually High Volume
TheStreet.com
Tuesday, October 2, 2012 - 11:56am
tags:
Illumina
Questcor: What's Really Changed?
Seeking Alpha
Tuesday, October 2, 2012 - 11:55am
tags:
Questcor, earnings
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tuesday, October 2, 2012 - 11:25am
tags:
Arqule, lung cancer, Daiichi Sankyo, tivantinib, non-small cell lung cancer
3 Giant Leaps for MannKind
Motley Fool
Tuesday, October 2, 2012 - 10:47am
tags:
MannKind, Afrezza
Pfizer, Novartis And Northwest Biotherapeutics In A Race For IVF Inspired Cancer Cure
Seeking Alpha
Tuesday, October 2, 2012 - 10:45am
tags:
Pfizer, Novartis, Northwest Biotherapeutics, In Vitro Fertilization, cancer
Healthcare Business Review: GenVec’s Conference Success, Neurocrine Begins Trials
Wall St. Cheat Sheet
Tuesday, October 2, 2012 - 10:30am
tags:
GenVec, Neurocrine, NBI-98854
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tuesday, October 2, 2012 - 10:05am
tags:
diabetes, JNJ, canagliflozin, Dapagliflozin, Bristol-Myers Squibb, AstraZeneca
Ablynx enters alliance with Merck worth up to 448 million euros
Reuters
Tuesday, October 2, 2012 - 9:54am
tags:
Ablynx, Merck
[video]Can Pharmacyclics Turn It Around?
Motley Fool
Tuesday, October 2, 2012 - 9:50am
tags:
Pharmacyclics
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Monday, October 1, 2012 - 9:52pm
tags:
M&A, AstraZeneca, Seattle Genetics, Regeneron, ONYX Pharmaceuticals, Biomarin, Forest Labs
Can Hemispherx Find Success In The Chronic Fatigue Market?
Seeking Alpha
Monday, October 1, 2012 - 9:49pm
tags:
chronic fatigue syndrome, Hemispherx, Ampligen
Cleveland BioLabs hepatocellular carcinoma drug granted orphan status by FDA
Yahoo/Fly the on Wall
Monday, October 1, 2012 - 9:46pm
tags:
orphan drugs, hepatocellular carcinoma, Cleveland BioLabs, Quinacrine
[video]Pfizer's Life After Lipitor: A 20% Rally Perhaps?
Bloomberg
Monday, October 1, 2012 - 9:44pm
tags:
Pfizer, patents, Lipitor, dividends
Merck’s HPV Vaccine Gardasil Shown Safe in Kaiser Study
Bloomberg
Monday, October 1, 2012 - 9:40pm
tags:
Merck, HPV, vaccines, Gardasil
Zogenix's Zohydro ER: A Safer Opioid For Chronic Pain
Seeking Alpha
Monday, October 1, 2012 - 9:39pm
tags:
Zogenix, Zohydro ER, chronic pain
Novartis Progresses with AIN457
Yahoo/Zacks.com
Monday, October 1, 2012 - 9:38pm
tags:
Novartis, AIN57, psoriasis
Novartis Banks on Meningitis Shot to Justify ‘Oops’ Deal
Bloomberg
Monday, October 1, 2012 - 12:48pm
tags:
Novartis, vaccines, meningitis, Bexsero, Chiron
Sequenom said customers not lost to competitors
The Fly on the Wall
Monday, October 1, 2012 - 12:47pm
tags:
Sequenom, Verinata, Ariosa
Vivus’s Weight-Loss Pill Covered by Insurers 30% of the Time
Bloomberg
Monday, October 1, 2012 - 12:31pm
tags:
Vivus, insurance, obesity, Qsymia
Novartis COPD drug Seebri gets thumbs-up in Europe
Pharma Times, UK
Monday, October 1, 2012 - 12:30pm
tags:
Novartis, COPD, Europe, Seebri Breezhaler

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.